Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
For me, it seems (?) nothing has changed, vis-a-viz ...
1. Interim results to be reported first,
2. Full (long covid) results to be reported next, and
3. Peer Review (intended pub. on 1 Mar)
Given no apparent changes (or at least none reported), then I guess interims have been ready for a while and were just waiting for 11/2 to pass, thus, I think 07.00 Mon 14th for interim results.
Full results thereafter circa. 21-28th Feb, and peer review on 1/3 (as intended - if no reported delay. All IMO.
(... and as suggested this may have been delayed until full 90-day review done, by Fri 111th)
As previously discussed, the possibility of separate RNS, days/weeks apart, giving isolated milestone news could deliver a very different SP graph to a single, multi-milestone update RNS. I would guess at the former, but simply the first RNS content / extent will hopefully confirm / hint which it will be. BO / TO possibilities will be the wild card.
Just could not contemplate selling anything. No matter how unlikely, the chance of an intraday RNS, and the fact we are right in the middle of RNS territory keeps me sitting on my hands. I do however admit to an irrational attraction to Valentines Day.
It just seems more likely to me that, firstly, there will be a few key RNs's to come out in relatively short order, and secondly, if the order that these come out go as generally expected, each subsequent one will have a greater effect of the SP than the previous. Any plan, for me will be dictated by the extent to which each RNS covers these milestones (interim results, final results, Peer review, EUA, orders, update on A2P3). SP graph may just end up looking like the Alps ... but in ascending order.
If I'm reading this right and 25 patients were asked only 2 questions (assuming the patients themselves provided the answers and therefore not highly technical or medical data answers) this would hardly take 17/11 - 31/1, unless the 25 were shared across the 17 countries and no just US? As others have said, not really the sort of data that would align well with highly technical P3 data from medical professionals. More likely something extra asked by FDA to fast-track EUA. Bodes well for 31/1 I hope.
... Courtesy of @AIMDetective ...
https://twitter.com/AIMdective/status/1484813435607130120?s=19
All very useful thoughts and considerations coming out. It's less about the actual SP for me initially but more about selling strategy relative to how things may play out. My thought is that news may be subject to separate RNS messages, where more than just P3 results summary is ready to be notified. Given SNG's clear PR and accurate messaging, it may be deemed prudent not to lose key news by adding to end of results, incase missed. If so, then depending if the 'gap' is minutes, hours, or days then several spikes may occur affecting decisions on when to take initial profit, or sell up in its a quick win some may want. Just another consideration to mull over.